3D Organotypic Cultures of Human HepaRG Cells: A Tool for In Vitro Toxicity Studies
Open accessThe DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
Drug-induced human hepatotoxicity is difficult to predict using the current in vitro systems. In this study, long-term 3D organotypic cultures of the human hepatoma HepaRG cell line were prepared using a high-throughput hanging drop method. The organotypic cultures were maintained for 3 weeks and assessed for (1) liver specific functions, including phase I enzyme and transporter activities, (2) expression of liver-specific proteins, and (3) responses to three drugs (acetaminophen, troglitazone, and rosiglitazone). Our results show that the organotypic cultures maintain high liver-specific functionality during 3 weeks of culture. The immunohistochemistry analyses illustrate that the organotypic cultures express liver-specific markers such as albumin, CYP3A4, CYP2E1, and MRP-2 throughout the cultivation period. Accordingly, the production rates of albumin and glucose, as well as CYP2E1 activity, were significantly higher in the 3D versus the 2D cultures. Toxicity studies show that the organotypic cultures are more sensitive to acetaminophen- and rosiglitazone-induced toxicity but less sensitive to troglitazone-induced toxicity than the 2D cultures. Furthermore, the EC50 value (2.7mM) for acetaminophen on the 3D cultures was similar to in vivo toxicity. In summary, the results from our study suggest that the 3D organotypic HepaRG culture is a promising in vitro tool for more accurate assessment of acute and also possibly for chronic drug-induced hepatotoxicity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The observed increased sensitivity in the 3D hLiMT versus the traditional 2D culture model is consistent with reports that 3D spheroid models produce better risk assessment of drug-induced hepatotoxicity (Gunness et al. 2013).”
From Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury (2017) · cites this paper as Gunness et al. 2013
Citations
Cites
Capturing complex 3D tissue physiology in vitro
Griffith, L. G., & Swartz, M. A. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1858 · Cited by 2,290
ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. I. ROLE OF DRUG METABOLISM
Mitchell, J. R., Jollow, D. J., Potter, W. Z., Davis, D. C., Gillette, J. R., & Brodie, B. B. (1973) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29663-x · Cited by 1,498
Infection of a human hepatoma cell line by hepatitis B virus
Gripon, P., Rumin, S., Urban, S., Le Seyec, J., Glaise, D., Cannie, I., Guyomard, C., Lucas, J., Trepo, C., & Guguen-Guillouzo, C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232137699 · Cited by 1,282
Recent advances in three‐dimensional multicellular spheroid culture for biomedical research
Lin, R., & Chang, H. (2008) · Biotechnology Journal · doi:10.1002/biot.200700228 · Cited by 1,264 · cited 3×
“, 2008), which is imperative for normal cell physiology and function (Griffith and Swartz, 2006; Lin et al., 2008; van Zijl and Mikulits, 2010).”
BackgroundAcetaminophen-induced Hepatic Necrosis
Jollow, D. J., Thorgeirsson, S. S., Potter, W. Z., Hashimoto, M., & Mitchell, J. R. (1974) · Pharmacology · doi:10.1159/000136547 · Cited by 1,092
Kelm, J. M., Timmins, N. E., Brown, C. J., Fussenegger, M., & Nielsen, L. K. (2003) · Biotechnology and Bioengineering · doi:10.1002/bit.10655 · Cited by 934
Aninat, C., Piton, A., Glaise, D., Le Charpentier, T., Langouët, S., Morel, F., Guguen-Guillouzo, C., & Guillouzo, A. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.006759 · Cited by 703
Guillouzo, A., Corlu, A., Aninat, C., Glaise, D., Morel, F., & Guguen-Guillouzo, C. (2007) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.12.003 · Cited by 675
LeCluyse, E. L. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00135-x · Cited by 477
Liver cell models in in vitro toxicology.
Guillouzo, A. (1998) · Environmental Health Perspectives · doi:10.1289/ehp.98106511 · Cited by 385
Research works printed but not linked: 1
- Watanabe, (1999), Was it not possible to predict liver dysfunction caused by troglitazone during the nonclinical safety studies?, Reevaluat. Safe, 30, 537
Cited by
Three-Dimensional Cell Cultures in Drug Discovery and Development
Fang, Y., & Eglen, R. M. (2017) · SLAS Discovery · doi:10.1177/1087057117696795 · Cited by 849
“Human liver organoids obtained using HepaRG cell line, a terminally differentiated hepatic cell line derived from a human hepatic progenitor cell line, have already been shown to produce human-specific metabolites.(117) This is particularly useful because human liver often metabolizes drugs in a manner distinct from a…”
BackgroundMethodNunes, A. S., Barros, A. S., Costa, E. C., Moreira, A. F., & Correia, I. J. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.26845 · Cited by 721
Complexity of dopamine metabolism
Meiser, J., Weindl, D., & Hiller, K. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-34 · Cited by 663
Ramaiahgari, S. C., den Braver, M. W., Herpers, B., Terpstra, V., Commandeur, J. N. M., van de Water, B., & Price, L. S. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1215-9 · Cited by 364
Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury
Proctor, W. R., Foster, A. J., Vogt, J., Summers, C., Middleton, B., Pilling, M. A., Shienson, D., Kijanska, M., Ströbel, S., Kelm, J. M., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2002-1 · Cited by 328
“The observed increased sensitivity in the 3D hLiMT versus the traditional 2D culture model is consistent with reports that 3D spheroid models produce better risk assessment of drug-induced hepatotoxicity (Gunness et al. 2013).”
Result
Metadata
- Authors
- Gunness, P., Mueller, D., Shevchenko, V., Heinzle, E., Ingelman-Sundberg, M., & Noor, F.
- Affiliations
- Karolinska Institutet (SE)
- Saarland University (DE)
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-02-01
- Volume
- 133
- Issue
- 1
- Pages
- 67-78
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- OpenAlex
- W2143495342
- Cited by
- 236
- References
- 73
- Citations by year
- 2026: 9 · 2025: 7 · 2024: 15 · 2023: 6 · 2022: 16 · 2021: 18 · 2020: 25 · 2019: 23 · 2018: 23 · 2017: 23 · 2016: 24 · 2015: 20 · 2014: 22 · 2013: 5
- FWCI
- 25.83
- Type
- journal article
- Language
- en
- Open access
- green
- orbilu.uni.lu
- Licence
- cc-by-nc-sa
- Locations
- Toxicological Sciences (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion, cc-by-nc-sa)
- Funders
- McGill University
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- HepaRG cells, 3D organotypic culture, drug-induced liver injury, acetaminophen toxicity, rosiglitazone, troglitazone, CYP2E1, CYP3A4, MRP2, albumin synthesis, phase I enzymes, drug transporters, in vitro toxicity testing, hanging drop method
- MeSH terms
- Cytochrome P450 Family 2, Rosiglitazone, Troglitazone, Acetaminophen, Multidrug Resistance-Associated Protein 2, ATP-Binding Cassette Sub-Family B Member 4, Albumins, Chromans, Cytochrome P-450 Enzyme System, Humans, Liver, Urea, ATP Binding Cassette Transporter, Subfamily B, Spheroids, Cellular, Cell Culture Techniques, Hepatocytes, Toxicity Tests, Acute, Thiazolidinediones, Cell Line, Tumor, High-Throughput Screening Assays
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.